skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: My energy holdings are comprised of two names, SGY (fallen from half to quarter position) and BP (Plc) (maintaining its half position). SGY should survive but hasn't really participated in any meaningful upswing. Is there any fundamental reason for its lacklustre performance compared to peers in this sector? Would it be worth maintaining this position (I've held on throughout all dividend cuts) or abandoning it for some other company in this sector?

Thanks
Read Answer Asked by mike on August 08, 2016
Q: Gentlemen

I am looking for a company to fill out my Real Estate space in my portfolio. Which of the above do you favour?

I am a conservative investor and with a good quality company be willing to hold for the long term.

Thanks
Read Answer Asked by Peter on August 08, 2016
Q: What do you think of this company which is a supplier of powertrain systems to most car companies. It seems to be a very stable company with a decent moat.

The only 2 things I can see is the vehicle market is slowing and their dept more than doubled over the past year (I think they issued notes recently).

Thank You,
Andrew
Read Answer Asked by Andrew on August 05, 2016
Q: I know it is way to small for you guys, but is it possible to get an opinion about future potential for EUO Eurocontrol.
One of the largest players in that sector SICPA now owns 12.4%. They are doing a share buy back up to 10% of the companies estimated public float , and insiders have decent positions

Thanks,
David
Read Answer Asked by David on August 05, 2016
Q: A year ago, Knight signed a deal to distribute 3 of Advaxis's products in Canada and bought about 400,000 shares at $13.91, a premium at the time from the Advaxis treasury. The shares tanked to $5, recovered to $8 and have jumped %6 to $14 in the past 3 days on the announcement that Amgen bought worldwide rights to another Advaxis drug and gave them $40 Million. This will help Knight as the shares appreciate but will it hurt their deal on the other 3 drugs they represent as Advaxis may concentrate on the behemoth deal with a super-large pharma co. and neglect their other products.
Knight's share price has help up well during the healthcare decline. Do you think they will one day do a big deal or continue to drip out their $600M in miniscule does? I am sure this company will be a blockbuster some day, but I may not live long enough to see it!
Thanks.
Read Answer Asked by Steven on August 05, 2016